These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12002908)

  • 21. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis.
    Woessner R; Grauer MT; Frese A; Bethke F; Ginger T; Hans A; Treib J
    Infection; 2006 Dec; 34(6):342-4. PubMed ID: 17180590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective.
    Gurfinkel E
    J Infect Dis; 2000 Jun; 181 Suppl 3():S566-8. PubMed ID: 10839760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic therapy after acute myocardial infarction: a prospective randomized study.
    Zahn R; Schneider S; Frilling B; Seidl K; Tebbe U; Weber M; Gottwik M; Altmann E; Seidel F; Rox J; Höffler U; Neuhaus KL; Senges J;
    Circulation; 2003 Mar; 107(9):1253-9. PubMed ID: 12628944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reduction of the expansion rate of small abdominal aortic aneurysms with roxithromycin. Results from a randomized controlled trial].
    Vammen S; Lindholt JS; Østergaard LJ; Fasting H; Henneberg EW
    Ugeskr Laeger; 2002 Dec; 164(50):5916-9. PubMed ID: 12553109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology.
    Liu R; Yamamoto M; Moroi M; Kubota T; Ono T; Funatsu A; Komatsu H; Tsuji T; Hara H; Hara H; Nakamura M; Hirai H; Yamaguchi T
    Am Heart J; 2005 Oct; 150(4):681-8. PubMed ID: 16209964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.
    Gurfinkel E; Bozovich G; Daroca A; Beck E; Mautner B
    Lancet; 1997 Aug; 350(9075):404-7. PubMed ID: 9259655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability.
    Romano S; Penco M; Fratini S; Di Pietro M; Sessa R; Del Piano M; Fedele F; Dagianti A
    Int J Cardiol; 2004 May; 95(1):95-9. PubMed ID: 15159045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
    Stone AF; Mendall MA; Kaski JC; Edger TM; Risley P; Poloniecki J; Camm AJ; Northfield TC
    Circulation; 2002 Sep; 106(10):1219-23. PubMed ID: 12208796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection.
    Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
    Scand J Infect Dis; 2004; 36(11-12):811-6. PubMed ID: 15764166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials.
    Wells BJ; Mainous AG; Dickerson LM
    Arch Intern Med; 2004 Oct; 164(19):2156-61. PubMed ID: 15505130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
    Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
    Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.